ACOT4 and ACOT6 Activate Akt-mTOR Pathway and Inhibit Calcium Oxalate-Induced Renal Tubular Cell Injury

Shenghan Wang1,2, Zhentao Lei3,4, Wei Liu3,4

  • 1Department of Urology, Aerospace Center Hospital, Beijing, China, wanghan73@hotmail.com.

Abstract

Insights

Acyl-coenzyme A thioesterases (ACOTs), specifically ACOT4 and ACOT6, protect against calcium oxalate kidney stone injury by reducing apoptosis and activating the Akt/mTOR pathway. These findings offer new therapeutic targets for kidney stone disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • Calcium oxalate (CaOx) kidney stones represent a significant chronic kidney disease burden.
  • Acyl-coenzyme A thioesterases (ACOTs) are key regulators of fatty acid metabolism, but their role in CaOx stone formation is unknown.

Purpose of the Study:

  • To investigate the role of ACOTs in the pathogenesis of CaOx kidney stone formation.
  • To explore the potential of ACOTs as therapeutic targets for CaOx kidney stones.

Main Methods:

  • Utilized HK-2 and M-1 cell lines and a mouse model of kidney stones induced by glyoxylic acid.
  • Manipulated ACOT4 and ACOT6 expression using siRNA and plasmid vectors.
  • Assessed cell viability, apoptosis, crystal adhesion, and LDH release.
  • Analyzed gene and protein expression via RT-qPCR and Western blotting.
  • Investigated the involvement of the Akt/mTOR signaling pathway.

Main Results:

  • CaOx treatment upregulated ACOT family members in kidney cells.
  • Knockdown of ACOT4/6 exacerbated CaOx-induced cell injury, crystal formation, and LDH release.
  • Overexpression of ACOT4/6 protected against CaOx-induced kidney cell injury.
  • ACOT4/6 modulated the Akt/mTOR pathway, with knockdown decreasing p-AKT and p-S6 levels.
  • ACOT4/6 knockdown promoted CaOx-induced apoptosis, which was reversed by an apoptosis inhibitor.

Conclusions:

  • ACOT4 and ACOT6 act as protective factors against CaOx-induced kidney cell injury.
  • These ACOTs exert protective effects by inhibiting apoptosis and activating the Akt/mTOR signaling pathway.
  • The findings provide novel insights into CaOx kidney stone formation and suggest ACOT4/6 as potential therapeutic targets.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
101
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K